These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 6361673)

  • 1. [Drill biopsy and puncture biopsy for the determination of hormone receptors].
    Magdelenat H
    Pathol Biol (Paris); 1983 Nov; 31(9):755-60. PubMed ID: 6361673
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunocytochemical assay of estrogen and progesterone receptors in fine needle aspirates from breast cancer patients.
    Nizzoli R; Bozzetti C; Savoldi L; Manotti L; Naldi N; Camisa R; Soresi AP; Guazzi A; Cocconi G
    Acta Cytol; 1994; 38(6):933-8. PubMed ID: 7992582
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Contribution of drill-biopsies to pre-treatment investigation of breast adenocarcinomas (author's transl)].
    Mauriac L; Wafflart J; Durand M; Parsi B; de Mascarel I; Trojani M; Meugé-Moraw C
    Bull Cancer; 1981; 68(5):417-21. PubMed ID: 7332789
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunocytochemical determination of estrogen and progesterone receptors and flow cytometric DNA analysis of breast cancer on fine needle aspirates.
    Marrazzo A; Russo A; Bazan V; Taormina P; Lupo F; Bazan P
    Anticancer Res; 1993; 13(6B):2435-40. PubMed ID: 8135480
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enzyme immunoassay of estrogen receptors in fine needle aspirates of breast tumors.
    Magdelenat H; Merle S; Zajdela A
    Cancer Res; 1986 Aug; 46(8 Suppl):4265s-4267s. PubMed ID: 3524807
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Surgical specimen can be replaced by core samples in assessment of ER, PR and HER-2 for invasive breast cancer.
    Sutela A; Vanninen R; Sudah M; Berg M; Kiviniemi V; Rummukainen J; Kataja V; Kärjä V
    Acta Oncol; 2008; 47(1):38-46. PubMed ID: 17851859
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Puncture cytology of the breast: correlation of visual and image analysis studies with hormone receptor status].
    Schenck U; Burger G; Jütting U; Peters-Welte C; Eiermann W
    Geburtshilfe Frauenheilkd; 1985 Jan; 45(1):17-21. PubMed ID: 3845025
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunocytochemical determination of estrogen and progesterone receptors on 219 fine-needle aspirates of breast cancer. A prospective study.
    Marrazzo A; Taormina P; Leonardi P; Lupo F; Filosto S
    Anticancer Res; 1995; 15(2):521-6. PubMed ID: 7763033
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Fine-needle aspiration biopsy and analysis of estrogen receptors in breast cancer].
    Benyahia B; Magdelenat H; Zajdela A; Vilcoq JR
    Bull Cancer; 1982; 69(5):456-60. PubMed ID: 7165807
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitative assessment of oestrogen and progesterone receptors on fine-needle aspirates and cryostat sections of breast carcinomas: how does this compare with biochemical assays?
    Muchiri LW
    East Afr Med J; 1993 May; 70(5):280-3. PubMed ID: 8306903
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estrogen receptor status in breast cancer.
    Wright CJ
    Can J Surg; 1980 Jul; 23(4):316-7. PubMed ID: 7417890
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Absence of progesterone receptor associated with secondary breast cancer in postmenopausal women.
    Balleine RL; Earl MJ; Greenberg ML; Clarke CL
    Br J Cancer; 1999 Mar; 79(9-10):1564-71. PubMed ID: 10188907
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biopathologic profile of breast cancer core biopsy: is it always a valid method?
    Cavaliere A; Sidoni A; Scheibel M; Bellezza G; Brachelente G; Vitali R; Bucciarelli E
    Cancer Lett; 2005 Jan; 218(1):117-21. PubMed ID: 15639347
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estimation of hormone receptor status in fine-needle aspirates and paraffin-embedded sections from breast cancer using the novel rabbit monoclonal antibodies SP1 and SP2.
    Cano G; Milanezi F; Leitão D; Ricardo S; Brito MJ; Schmitt FC
    Diagn Cytopathol; 2003 Oct; 29(4):207-11. PubMed ID: 14506673
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Place of hormone receptor determination in the therapeutic strategy of breast cancer].
    Clavel B; Gest J
    Pathol Biol (Paris); 1983 Dec; 31(10):809-18. PubMed ID: 6366702
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Immunohistochemical determination of hormonal receptors on cell-blocks from fine-needle cytopunctures of breast carcinoma].
    Briffod M; Le Doussal V; Spyratos F
    Bull Cancer; 2001 Oct; 88(10):1028-35. PubMed ID: 11713039
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Cell picture and hormone receptor status--visual and image analytical studies of breast cancers].
    Schenck U; Burger G; Jütting U; Eiermann W
    Verh Dtsch Ges Pathol; 1985; 69():529-31. PubMed ID: 4096123
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of operative devascularization on estrogen and progesterone receptor levels in breast cancer specimens.
    Teicher I; Tinker MA; Auguste LJ; Laufer H; Stein TA; Wise L
    Surgery; 1985 Oct; 98(4):784-91. PubMed ID: 4049250
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preoperative assessment of proliferative activity and hormonal receptor status in carcinoma of the breast: a comparison of needle aspiration and needle-core biopsies to the surgical specimen.
    Railo M; Nordling S; Krogerus L; Sioris T; von Smitten K
    Diagn Cytopathol; 1996 Sep; 15(3):205-10. PubMed ID: 8955602
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Simultaneous immunohistochemical and biochemical hormone receptor assessment in breast cancer provides complementary prognostic information.
    Biesterfeld S; Schröder W; Steinhagen G; Koch R; Veuskens U; Schmitz FJ; Handt S; Böcking A
    Anticancer Res; 1997; 17(6D):4723-9. PubMed ID: 9494596
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.